Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
54% of physicians concerned about FDA nominee Dr. Scott Gottlieb's conflicts of interest
54% of physicians concerned about FDA nominee Dr. Scott Gottlieb's conflicts of interest
http://www.beckershospitalreview.com/hospital-management-administration/survey-54-of-physicians-concerned-about-fda-nominee-dr-scott-gottlieb-s-conflicts-of-interest.html
Physicians are divided on the potential appointment of Scott Gottlieb, MD, as commissioner of the Food and Drug Administration, according to a survey from MDLinx, an online physician forum.
The survey polled 527 MDLinx physicians for their opinions on Dr. Gottlieb, who previously served as the FDA deputy commissioner for policy. MDLinx found 54.5 percent of respondents were concerned Dr. Gottlieb's consulting work presented a potential conflict of interest with the FDA job.
"We all know that the FDA is run more by financial interests than true science," one respondent wrote in the comments section of the survey. "I do not think he will lead the FDA in any meaningful way away from that sad tradition."
Respondent opinions were scattered, however, on how effectual Dr. Gottlieb would be in the head FDA role. Of those surveyed, 24.4 percent said they thought he "may be good" for the pharmaceutical regulatory process, while 21.8 percent said his appointment "may harm" the process. Slightly more than 19 percent of respondents were unsure and 15.6 percent said they felt the appointment would be "very bad" for the pharmaceutical regulatory process.
http://www.beckershospitalreview.com/hospital-management-administration/survey-54-of-physicians-concerned-about-fda-nominee-dr-scott-gottlieb-s-conflicts-of-interest.html
Physicians are divided on the potential appointment of Scott Gottlieb, MD, as commissioner of the Food and Drug Administration, according to a survey from MDLinx, an online physician forum.
The survey polled 527 MDLinx physicians for their opinions on Dr. Gottlieb, who previously served as the FDA deputy commissioner for policy. MDLinx found 54.5 percent of respondents were concerned Dr. Gottlieb's consulting work presented a potential conflict of interest with the FDA job.
"We all know that the FDA is run more by financial interests than true science," one respondent wrote in the comments section of the survey. "I do not think he will lead the FDA in any meaningful way away from that sad tradition."
Respondent opinions were scattered, however, on how effectual Dr. Gottlieb would be in the head FDA role. Of those surveyed, 24.4 percent said they thought he "may be good" for the pharmaceutical regulatory process, while 21.8 percent said his appointment "may harm" the process. Slightly more than 19 percent of respondents were unsure and 15.6 percent said they felt the appointment would be "very bad" for the pharmaceutical regulatory process.
